Lipoprotein(a): Medical Treatment Options for an Elusive Molecule

E-ISSN： 1873-4286|17|9|871-876

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.9, 2011-01, pp. : 871-876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein(a) Management: Pharmacological and Apheretic Treatment

Current Medicinal Chemistry, Vol. 24, Iss. 10, 2017-05 ,pp. : 957-968

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)?

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1562-1570

Bentham Science Publishers

Access to resources Recommend Favorite

Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options

By Gur Serap Limin Ma Hellstrom Wayne JG

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 931-944

Informa Healthcare

Access to resources Recommend Favorite

New medical options for liver tumours

By Williams Sarah Palmer Daniel Johnson Philip

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 351-356

Royal College Of Physicians

Access to resources Recommend Favorite

Kleptomania: Diagnosis and Treatment Options

By Durst R.

CNS Drugs, Vol. 15, Iss. 3, 2001-01 ,pp. : 185-195

Adis International

Access to resources Recommend Favorite